Related Experiment Videos
Problems with the leukocyte migration inhibition technique in the study of human tumor immunity
National Cancer Institute Monograph
|June 1, 1973
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
A pilot study of the combination of interleukin-2-based immunotherapy and radiation therapy.
Journal of immunotherapy : official journal of the Society for Biological Therapy·1992
The Stanford experience with combined procarbazine, Alkeran and vinblastine (PAVe) and radiotherapy for locally extensive and advanced stage Hodgkin's disease.
Annals of oncology : official journal of the European Society for Medical Oncology·1992
Recognition of shared melanoma antigens by human tumor-infiltrating lymphocytes.
Journal of immunotherapy : official journal of the Society for Biological Therapy·1992
The use of congenitally immunodeficient mice to study human tumor metastases and immunotherapy.
Journal of immunotherapy : official journal of the Society for Biological Therapy·1992
In vivo activity of tumor necrosis factor (TNF) mutants. Secretory but not membrane-bound TNF mediates the regression of retrovirally transduced murine tumor.
Journal of immunology (Baltimore, Md. : 1950)·1992
Second cancer following cancer of the breast in Connecticut, 1935-82.
National Cancer Institute monograph·1985
Second cancer following cancer of the respiratory system in Connecticut, 1935-1982.
National Cancer Institute monograph·1985
Second cancer following cancer of the digestive system in Connecticut, 1935-82.
National Cancer Institute monograph·1985
Summary: multiple primary cancers in Denmark, 1943-80.
National Cancer Institute monograph·1985
Second cancer following lymphatic and hematopoietic cancers in Denmark, 1943-80.
National Cancer Institute monograph·1985
Second cancer following cutaneous melanoma and cancers of the brain, thyroid, connective tissue, bone, and eye in Denmark, 1943-80.
National Cancer Institute monograph·1985
Spatial statistics infer structured immune signatures in primary prostate cancer.
Cancer immunology research·2026
Integrated molecular and immune profiling identifies FOXA1 as a complementary co-target to MUC1 for bispecific immunotherapy in breast cancer.
Functional & integrative genomics·2026
Incidental Thyroid Uptake on 18F-FES PET/CT Revealing Papillary Thyroid Carcinoma.
Clinical nuclear medicine·2026
IL-23 promotes PD-L1 expression and tumor immune evasion via METTL16 pathway.
American journal of cancer research·2026